Research Prize

In 2024, UEG will award € 50,000 for excellence in basic science, translational or clinical research. 

With this prize we support a future scientific research project from early stage to successful conclusion. The prize addresses well-established researchers at the height of their active career, whose science has had or will have a crucial impact on digestive health.

Application for the Research Prize 2024 is open until March 1, 2024.

• Active, well-established senior researchers at the height of their active career, whose science has had or will have a crucial impact on digestive health.
• Applicants should be leading a substantial research group and their work should be conducted predominantly in Europe.
• The work should have been supported by substantial peer reviewed grants through internationally recognised research councils, research charities or industrial partners.
• Applicants must have been mentioned at least once as (co-)author of an abstract submitted to UEG Week - or have been awarded as Rising Stars - in the past 3 years (2021, 2022, and/or 2023). 
• Applicants must commit to deliver the agreed research within the stipulated time frame. 
• Applications from departments that received a Research Prize in the previous 5 years (2019-2023) will not be accepted.  
• The prize will be awarded to the same recipient only once.
• This prize is open to all myUEG Associates.  
• We encourage candidates from all digestive health fields to apply.
• For further details, read our application criteria.

To apply, please follow these steps: 

Download official call & criteria
Download application form  

Apply  

Michael Bretthauer, is Professor of Medicine at the University of Oslo and Gastroenterologist at Oslo University Hospital. He is also an Associate Editor of Annals of Internal Medicine and chair of the Clinical Research Center, Department of Transplantation Medicine at Oslo University Hospital.

Michael Bretthauer’s main clinical activities are in gastrointestinal endoscopy, especially in colonoscopy and colorectal cancer and polyps. His main research interests include clinical trials and clinical epidemiology in gastroenterology. He is a lead investigator for several large-scale international clinical trials in colorectal cancer screening and surveillance, such as the Nordic-European Initiative on Colorectal Cancer and the European Polyp Surveillance trials. Michael Bretthauer has published more than 300 scientific articles and his current H-index for citation is 52. 

Together with his wife Mette Kalager, an internationally recognized expert in medical decision making and clinical epidemiology, Michael Bretthauer has since 2012 built up an internationally competitive clinical research environment in Oslo, the so-called Clinical Effectiveness Group. The group has today around 35 active members of academic faculty, PhD and post doc level scientists, clinicians, study nurses and support staff. The group and its partners are running clinical trials and epidemiology studies in gastroenterology across Scandinavia and Europe with altogether more than 400,000 enrolled patients. 

Michael Bretthauer received his award in the UEG Week Opening Plenary. Watch the recording now!